We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Novel S-Layer Intranasal and Oral COVID-19 Vaccine Could Decrease Severity of SARS-CoV-2 Infection

By HospiMedica International staff writers
Posted on 29 Jun 2020
Print article
Image: Avalon GloboCare Corp. is developing the S-layer vaccine in partnership with the University of Natural Resources and Life Sciences (Photo courtesy of Avalon GloboCare Corp.)
Image: Avalon GloboCare Corp. is developing the S-layer vaccine in partnership with the University of Natural Resources and Life Sciences (Photo courtesy of Avalon GloboCare Corp.)
Scientists are developing a novel S-layer SARS-CoV-2 vaccine that can be administered by an intranasal or oral route and would induce a sufficient immune response to prevent a severe form of COVID-19, which causes morbidity and often mortality.

Avalon GloboCare Corp. (Freehold, NJ, USA), a clinical-stage global developer of cell-based technologies and therapeutics, is developing the S-layer vaccine in partnership with the University of Natural Resources and Life Sciences (BOKU Vienna, Austria). BOKU’s Professor Uwe B. Sleytr, an eminent member of the Austrian Academy of Sciences, is a pioneer of applied surface layer (S-layer) nanotechnology, based on the repetitive protein structures that make up the outer surface of microbial cells. The research is part of an ongoing and broader collaboration between Avalon and BOKU that will utilize S-layer technology to accelerate additional vaccine programs for other respiratory infections including different strains of the flu (influenza A/B), respiratory syncytial virus (RSV), and other viruses. As part of the partnership, Avalon is also actively exploring other practical uses of S-layer technology including targeted drug delivery, diagnostic devices, and therapeutic applications.

The COVID-19 vaccine candidate is derived from a fusion of an S-layer viral particle mimic with the SARS-CoV-2 spike protein and could be delivered non-invasively via the nasal or oral passageways, rather than a needle-based injection into the muscle or under the skin. The S-layer protein-based vaccine is expected to both decrease the severity of a SARS-CoV-2 infection, preventing the more severe respiratory inflammation and organ damage seen in many COVID-19 patients, and build immunity against the virus. The investigators have already made substantial progress by developing the proprietary techniques necessary to synthesize conjugate vaccines consisting of an S-layer artificial viral envelope linked to a viral antigen. As a proof of concept, they have also shown that these types of protein conjugate vaccine candidates are able to elicit immune-protective antibody responses.

“We are encouraged by the progress we have made so far to develop a novel COVID-19 vaccine during this unprecedented world-wide health crisis,” said David Jin, M.D., Ph.D., President and Chief Executive Officer of Avalon GloboCare. “We are working swiftly and diligently with BOKU to complete the laboratory testing and characterization of the S-layer fusion protein SARS-CoV-2 vaccine candidate. We believe that our novel vaccine approach has the potential to be effective. Importantly, this vaccine candidate could be manufactured and delivered more rapidly compared to traditional vaccines, providing access and immunization to a larger population of people around the globe to help combat the COVID-19 pandemic.”

Related Links:
Avalon GloboCare Corp.
University of Natural Resources and Life Sciences


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Flocked Fiber Swabs
Puritan® patented HydraFlock®
New
Doppler String Phantom
CIRS Model 043A
New
Pneumatic Stool
Avante 5-Leg Pneumatic Stool

Print article
Radcal

Channels

Critical Care

view channel
mage: The electroceutical epidermal patch is designed to inhibit bacterial growth (Photo courtesy of Saehyun Kim/University of Chicago)

Cutting-Edge Bioelectronic Device Offers Drug-Free Approach to Managing Bacterial Infections

Antibiotic-resistant infections pose an increasing threat to patient safety and healthcare systems worldwide. Recent estimates indicate that drug-resistant infections may rise by 70% by 2050, highlighting... Read more

Surgical Techniques

view channel
Image: Conceptual schematic showing microgrippers (µ-grippers) operating as biopsy tools in the upper urinary tract (Photo courtesy of Wangqu Liu, Yan Wan/Gracias Lab, Johns Hopkins University)

Microgrippers For Miniature Biopsies to Create New Cancer Diagnostic Screening Paradigm

The standard diagnosis of upper urinary tract cancers typically involves the removal of suspicious tissue using forceps, a procedure that is technically challenging and samples only a single region of the organ.... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more